Outpace Bio is a biotechnology company that develops smart cell therapies using protein design and synthetic biology. It offers a platform that combines custom-designed biological functions with cellular control modalities using cellular biology to deal with incurable diseases. The company works on the development and commercialization of a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders.